Targeted retinoblastoma management: when to use intravenous, intra-arterial, periocular, and intravitreal chemotherapy
CL Shields, SE Lally, AM Leahey… - Current opinion in …, 2014 - journals.lww.com
Targeted retinoblastoma management: when to use intravenous,... : Current Opinion in
Ophthalmology Targeted retinoblastoma management: when to use intravenous, intra-arterial …
Ophthalmology Targeted retinoblastoma management: when to use intravenous, intra-arterial …
Continuing challenges in the management of retinoblastoma with chemotherapy
CL Shields, AT Meadows, AM Leahey, JA Shields - Retina, 2004 - journals.lww.com
The management of retinoblastoma has gradually changed over the past 10 years. Over
95% of children with retinoblastoma in the United States are cured with modern techniques …
95% of children with retinoblastoma in the United States are cured with modern techniques …
The International Classification of Retinoblastoma predicts chemoreduction success
CL Shields, A Mashayekhi, AK Au, C Czyz, A Leahey… - Ophthalmology, 2006 - Elsevier
PURPOSE: To evaluate the reliability of the International Classification of Retinoblastoma
(ICRB) for predicting treatment success with chemoreduction (CRD). DESIGN …
(ICRB) for predicting treatment success with chemoreduction (CRD). DESIGN …
A revision of the intensity of treatment rating scale: classifying the intensity of pediatric cancer treatment
AE Kazak, MC Hocking, RF Ittenbach… - Pediatric blood & …, 2012 - Wiley Online Library
Background We previously developed a reliable and valid method for classifying the
intensity of pediatric cancer treatment. The Intensity of Treatment Rating Scale (ITR‐2.0) 1 …
intensity of pediatric cancer treatment. The Intensity of Treatment Rating Scale (ITR‐2.0) 1 …
Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions
DL Porter, RH Collins Jr, C Hardy… - Blood, The Journal …, 2000 - ashpublications.org
The efficacy and toxicity of donor leukocyte infusions (DLI) after unrelated donor bone
marrow transplantation (BMT) is largely unknown. We identified 58 recipients of unrelated …
marrow transplantation (BMT) is largely unknown. We identified 58 recipients of unrelated …
Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma
S Kaliki, CL Shields, SU Shah, RC Eagle… - Archives of …, 2011 - jamanetwork.com
Background Analysis of 52 eyes with high-risk retinoblastoma managed with
postenucleation adjuvant chemotherapy using vincristine sulfate, etoposide phosphate, and …
postenucleation adjuvant chemotherapy using vincristine sulfate, etoposide phosphate, and …
Second malignant neoplasms following chemoreduction with carboplatin, etoposide, and vincristine in 245 patients with intraocular retinoblastoma
K Turaka, CL Shields, AT Meadows… - Pediatric blood & …, 2012 - Wiley Online Library
Background To evaluate the occurrence of second malignant neoplasms (SMN) following
chemoreduction (CRD) with carboplatin, vincristine, and etoposide (CEV) as frontline …
chemoreduction (CRD) with carboplatin, vincristine, and etoposide (CEV) as frontline …
Management of advanced retinoblastoma with intravenous chemotherapy then intra-arterial chemotherapy as alternative to enucleation
CL Shields, S Kaliki, S Al-Dahmash, D Rojanaporn… - Retina, 2013 - journals.lww.com
Purpose: To determine the efficacy of primary intravenous chemotherapy (IVC) plus
secondary intraarterial chemotherapy (IAC) for patients with advanced retinoblastoma …
secondary intraarterial chemotherapy (IAC) for patients with advanced retinoblastoma …
[HTML][HTML] Unilateral retinoblastoma managed with intravenous chemotherapy versus intra-arterial chemotherapy. Outcomes based on the international classification of …
CL Shields, R Jorge, EAT Say, G Magrath… - Asia-Pacific Journal of …, 2016 - Elsevier
Purpose The objective of this study was to compare outcomes after intravenous
chemotherapy (IVC) versus intra-arterial chemotherapy (IAC) for unilateral retinoblastoma …
chemotherapy (IVC) versus intra-arterial chemotherapy (IAC) for unilateral retinoblastoma …
Retinoblastoma regression patterns following chemoreduction and adjuvant therapy in 557 tumors
CL Shields, M Palamar, P Sharma… - Archives of …, 2009 - jamanetwork.com
Objective To evaluate retinoblastoma regression patterns following chemoreduction and
adjuvant therapy. Participants A total of 557 retinoblastomas. Methods A retrospective …
adjuvant therapy. Participants A total of 557 retinoblastomas. Methods A retrospective …